2018
DOI: 10.1080/09513590.2018.1519795
|View full text |Cite
|
Sign up to set email alerts
|

Elevation of the adiponectin/leptin ratio in women with gestational diabetes mellitus after supplementation with alpha-lipoic acid

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0
8

Year Published

2020
2020
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 27 publications
0
7
0
8
Order By: Relevance
“…The 14 excluded studies along with the reason of their exclusion are presented in Table S1 . Three studies were included in the systematic review but not in the quantitative synthesis because one did not provide necessary descriptive statistic measures [ 19 ], and in the two other studies the outcome measures did not match the predefined primary and secondary outcomes [ 20 , 21 ]. Finally, 16 studies of 1173 women with GDM, were included in the quantitative synthesis (meta-analysis).…”
Section: Resultsmentioning
confidence: 99%
“…The 14 excluded studies along with the reason of their exclusion are presented in Table S1 . Three studies were included in the systematic review but not in the quantitative synthesis because one did not provide necessary descriptive statistic measures [ 19 ], and in the two other studies the outcome measures did not match the predefined primary and secondary outcomes [ 20 , 21 ]. Finally, 16 studies of 1173 women with GDM, were included in the quantitative synthesis (meta-analysis).…”
Section: Resultsmentioning
confidence: 99%
“…Overall, these data represent the first evidence that Myo is able to improve endothelial stress/damage in vascular cells by modulating inflammation and oxidative stress related to diabetes. These effects are comparable to the protective vascular action of LA, a molecule with well-known antioxidant effects that has demonstrated safety as well as beneficial effects on glycemia and liver enzymes as well as on lipid profiles and on adiponectin/leptin ratios in women affected by either GDM or polycystic ovary syndrome [ 8 , 27 , 30 , 31 , 32 , 33 ].…”
Section: Discussionmentioning
confidence: 95%
“…Although triglycerides metabolism is prevalent in pregnant subjects, an excess level of triglycerides metabolism is a sign of gestational diabetes mellitus (GDM) (Aslfalah, Jamilian, & Khosrowbeygi, 2019; Aslfalah, Jamilian, Rafiei, & Khosrowbeygi, 2019). It was observed that daily administration of α‐LA (100 mg, 8 weeks) during pregnancy to patients suffering from GDM decreased insulin resistance and elevated adiponectin level (Aslfalah, Jamilian, & Khosrowbeygi, 2019; Bo et al, 2004) (Table 1).…”
Section: Clinical Trial Studiesmentioning
confidence: 99%